ID   UGGG1_HUMAN             Reviewed;        1555 AA.
AC   Q9NYU2; Q53QP2; Q53SL3; Q8IW30; Q9H8I4;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 3.
DT   28-JAN-2026, entry version 195.
DE   RecName: Full=UDP-glucose:glycoprotein glucosyltransferase 1;
DE            Short=UGT1;
DE            Short=hUGT1;
DE            EC=2.4.1.- {ECO:0000269|PubMed:24415556};
DE   AltName: Full=UDP--Glc:glycoprotein glucosyltransferase;
DE   AltName: Full=UDP-glucose ceramide glucosyltransferase-like 1;
DE   Flags: Precursor;
GN   Name=UGGT1;
GN   Synonyms=GT, UGCGL1, UGGT, UGT1 {ECO:0000303|PubMed:10694380}, UGTR
GN   {ECO:0000250|UniProtKB:Q9JLA3};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAF66232.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, INDUCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF ASP-1452; GLN-1453; ASP-1454; LEU-1455; PRO-1456 AND
RP   ASN-1457.
RC   TISSUE=Fetal liver {ECO:0000312|EMBL:AAF66232.1};
RX   PubMed=10694380; DOI=10.1021/bi9916473;
RA   Arnold S.M., Fessler L.I., Fessler J.H., Kaufman R.J.;
RT   "Two homologues encoding human UDP-glucose:glycoprotein glucosyltransferase
RT   differ in mRNA expression and enzymatic activity.";
RL   Biochemistry 39:2149-2163(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000312|EMBL:AAH41098.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye {ECO:0000312|EMBL:AAH41098.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:BAB14632.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 710-1555 (ISOFORMS 1/2).
RC   TISSUE=Placenta {ECO:0000312|EMBL:BAB14632.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1277, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [7]
RP   INTERACTION WITH METTL23.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine methyltransferases
RT   preferentially interact with molecular chaperones to regulate their
RT   activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [8]
RP   FUNCTION, ACTIVITY REGULATION, INTERACTION WITH SELENOF, AND MUTAGENESIS OF
RP   ASP-1358.
RX   PubMed=24415556; DOI=10.1093/glycob/cwt163;
RA   Takeda Y., Seko A., Hachisu M., Daikoku S., Izumi M., Koizumi A.,
RA   Fujikawa K., Kajihara Y., Ito Y.;
RT   "Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are
RT   enzymatically active.";
RL   Glycobiology 24:344-350(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Recognizes glycoproteins with minor folding defects.
CC       Reglucosylates single N-glycans near the misfolded part of the protein,
CC       thus providing quality control for protein folding in the endoplasmic
CC       reticulum. Reglucosylated proteins are recognized by calreticulin for
CC       recycling to the endoplasmic reticulum and refolding or degradation.
CC       {ECO:0000269|PubMed:10694380}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(4)-(alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-
CC         (1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-
CC         alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-
CC         GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein] (N-glucan
CC         mannose isomer 9A1,2,3B1,2,3) + UDP-alpha-D-glucose = N(4)-(alpha-D-
CC         Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-
CC         [alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-
CC         Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-
CC         (1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein] + UDP + H(+);
CC         Xref=Rhea:RHEA:61304, Rhea:RHEA-COMP:14356, Rhea:RHEA-COMP:14357,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58223, ChEBI:CHEBI:58885,
CC         ChEBI:CHEBI:59080, ChEBI:CHEBI:139493;
CC         Evidence={ECO:0000269|PubMed:10694380};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:10694380};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:10694380};
CC   -!- ACTIVITY REGULATION: Catalytic activity is enhanced by complex
CC       formation with SELENOF. {ECO:0000269|PubMed:24415556}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:10694380, ECO:0000269|PubMed:15815621}.
CC   -!- SUBUNIT: Monomer as well as in a tight complex with SELENOF
CC       (PubMed:24415556). Interacts with METTL23 (PubMed:23349634). Part of a
CC       large chaperone multiprotein complex comprising DNAJB11, HSP90B1,
CC       HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1, UGGT1 and very small
CC       amounts of ERP29, but not, or at very low levels, CALR nor CANX (By
CC       similarity). {ECO:0000250|UniProtKB:Q9JLA3,
CC       ECO:0000269|PubMed:23349634, ECO:0000269|PubMed:24415556}.
CC   -!- INTERACTION:
CC       Q9NYU2; P04439: HLA-A; NbExp=2; IntAct=EBI-1056389, EBI-1042870;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000255|PROSITE-
CC       ProRule:PRU10138, ECO:0000269|PubMed:10694380}. Endoplasmic reticulum-
CC       Golgi intermediate compartment {ECO:0000255|PROSITE-ProRule:PRU10138,
CC       ECO:0000269|PubMed:10694380}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NYU2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYU2-2; Sequence=VSP_036508;
CC   -!- TISSUE SPECIFICITY: Higher levels in pancreas, skeletal muscle, kidney,
CC       and brain. Low levels in lung and heart. {ECO:0000269|PubMed:10694380}.
CC   -!- INDUCTION: By tunicamycin and A23187. Induced 3-4 fold 10 hours after
CC       treatment. {ECO:0000269|PubMed:10694380}.
CC   -!- DOMAIN: The N-terminal non-catalytic domain is assumed to mediate
CC       recognition of proteins with partial folding defects. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 8 family.
CC       {ECO:0000269|PubMed:10694380}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY14885.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAB14632.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF227905; AAF66232.1; -; mRNA.
DR   EMBL; AC017079; AAY14735.1; -; Genomic_DNA.
DR   EMBL; AC108059; AAY14885.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC041098; AAH41098.1; -; mRNA.
DR   EMBL; AK023671; BAB14632.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2154.1; -. [Q9NYU2-1]
DR   RefSeq; NP_064505.1; NM_020120.4. [Q9NYU2-1]
DR   AlphaFoldDB; Q9NYU2; -.
DR   SMR; Q9NYU2; -.
DR   BioGRID; 121217; 284.
DR   FunCoup; Q9NYU2; 2811.
DR   IntAct; Q9NYU2; 118.
DR   MINT; Q9NYU2; -.
DR   STRING; 9606.ENSP00000259253; -.
DR   CAZy; GT24; Glycosyltransferase Family 24.
DR   GlyConnect; 1871; 6 N-Linked glycans (1 site).
DR   GlyCosmos; Q9NYU2; 4 sites, 7 glycans.
DR   GlyGen; Q9NYU2; 7 sites, 28 N-linked glycans (3 sites), 2 O-linked glycans (3 sites).
DR   iPTMnet; Q9NYU2; -.
DR   MetOSite; Q9NYU2; -.
DR   PhosphoSitePlus; Q9NYU2; -.
DR   SwissPalm; Q9NYU2; -.
DR   BioMuta; UGGT1; -.
DR   DMDM; 224471872; -.
DR   CPTAC; CPTAC-290; -.
DR   jPOST; Q9NYU2; -.
DR   MassIVE; Q9NYU2; -.
DR   PaxDb; 9606-ENSP00000259253; -.
DR   PeptideAtlas; Q9NYU2; -.
DR   PRIDE; Q9NYU2; -.
DR   ProteomicsDB; 83277; -. [Q9NYU2-1]
DR   ProteomicsDB; 83278; -. [Q9NYU2-2]
DR   Pumba; Q9NYU2; -.
DR   Antibodypedia; 2454; 147 antibodies from 27 providers.
DR   DNASU; 56886; -.
DR   Ensembl; ENST00000259253.11; ENSP00000259253.6; ENSG00000136731.14. [Q9NYU2-1]
DR   GeneID; 56886; -.
DR   KEGG; hsa:56886; -.
DR   MANE-Select; ENST00000259253.11; ENSP00000259253.6; NM_020120.4; NP_064505.1.
DR   UCSC; uc002tps.4; human. [Q9NYU2-1]
DR   AGR; HGNC:15663; -.
DR   ClinPGx; PA38014; -.
DR   CTD; 56886; -.
DR   DisGeNET; 56886; -.
DR   GeneCards; UGGT1; -.
DR   HGNC; HGNC:15663; UGGT1.
DR   HPA; ENSG00000136731; Low tissue specificity.
DR   MIM; 605897; gene.
DR   OpenTargets; ENSG00000136731; -.
DR   VEuPathDB; HostDB:ENSG00000136731; -.
DR   eggNOG; KOG1879; Eukaryota.
DR   GeneTree; ENSGT00390000004600; -.
DR   HOGENOM; CLU_002668_1_1_1; -.
DR   InParanoid; Q9NYU2; -.
DR   OMA; RQTKTRF; -.
DR   OrthoDB; 27683at2759; -.
DR   PAN-GO; Q9NYU2; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9NYU2; -.
DR   PathwayCommons; Q9NYU2; -.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   SignaLink; Q9NYU2; -.
DR   UniPathway; UPA00378; -.
DR   Agora; ENSG00000136731; -.
DR   BioGRID-ORCS; 56886; 16 hits in 1161 CRISPR screens.
DR   ChiTaRS; UGGT1; human.
DR   GenomeRNAi; 56886; -.
DR   Pharos; Q9NYU2; Tbio.
DR   PRO; PR:Q9NYU2; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9NYU2; protein.
DR   Bgee; ENSG00000136731; Expressed in calcaneal tendon and 189 other cell types or tissues.
DR   ExpressionAtlas; Q9NYU2; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:GOC.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0003980; F:UDP-glucose:glycoprotein glucosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0051084; P:'de novo' post-translational protein folding; TAS:UniProtKB.
DR   GO; GO:1904380; P:endoplasmic reticulum mannose trimming; TAS:Reactome.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IBA:GO_Central.
DR   CDD; cd06432; GT8_HUGT1_C_like; 1.
DR   FunFam; 3.90.550.10:FF:000004; UDP-glucose glycoprotein glucosyltransferase 1; 1.
DR   Gene3D; 3.90.550.10; Spore Coat Polysaccharide Biosynthesis Protein SpsA, Chain A; 1.
DR   InterPro; IPR040497; Glyco_transf_24.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR009448; UDP-g_GGtrans.
DR   InterPro; IPR040693; UGGT_TRXL_1.
DR   InterPro; IPR040694; UGGT_TRXL_2.
DR   InterPro; IPR040692; UGGT_TRXL_3.
DR   InterPro; IPR040525; UGGT_TRXL_4.
DR   PANTHER; PTHR11226; UDP-GLUCOSE GLYCOPROTEIN:GLUCOSYLTRANSFERASE; 1.
DR   PANTHER; PTHR11226:SF3; UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 1; 1.
DR   Pfam; PF18404; Glyco_transf_24; 1.
DR   Pfam; PF18400; Thioredoxin_12; 1.
DR   Pfam; PF18401; Thioredoxin_13; 1.
DR   Pfam; PF18402; Thioredoxin_14; 1.
DR   Pfam; PF18403; Thioredoxin_15; 1.
DR   Pfam; PF06427; UDP-g_GGTase; 1.
DR   SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Signal; Transferase.
FT   SIGNAL          1..42
FT                   /evidence="ECO:0000250"
FT   CHAIN           43..1555
FT                   /note="UDP-glucose:glycoprotein glucosyltransferase 1"
FT                   /id="PRO_0000012271"
FT   REGION          1244..1555
FT                   /note="Glucosyltransferase"
FT                   /evidence="ECO:0000250"
FT   REGION          1534..1555
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1552..1555
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10138"
FT   MOD_RES         1277
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   CARBOHYD        536
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1228
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..24
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036508"
FT   MUTAGEN         1358
FT                   /note="D->A: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:24415556"
FT   MUTAGEN         1452..1457
FT                   /note="Missing: Inactive."
FT   MUTAGEN         1452
FT                   /note="D->A: Inactive."
FT                   /evidence="ECO:0000269|PubMed:10694380"
FT   MUTAGEN         1453
FT                   /note="Q->A: 4% active."
FT                   /evidence="ECO:0000269|PubMed:10694380"
FT   MUTAGEN         1454
FT                   /note="D->A: Inactive."
FT                   /evidence="ECO:0000269|PubMed:10694380"
FT   MUTAGEN         1455
FT                   /note="L->A: 2% active."
FT                   /evidence="ECO:0000269|PubMed:10694380"
FT   MUTAGEN         1456
FT                   /note="P->A: 41% active."
FT                   /evidence="ECO:0000269|PubMed:10694380"
FT   MUTAGEN         1457
FT                   /note="N->A: 7% active."
FT                   /evidence="ECO:0000269|PubMed:10694380"
FT   CONFLICT        1487
FT                   /note="A -> T (in Ref. 4; BAB14632)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1555 AA;  177190 MW;  0A5274A4A65152D3 CRC64;
     MGCKGDASGA CAAGALPVTG VCYKMGVLVV LTVLWLFSSV KADSKAITTS LTTKWFSTPL
     LLEASEFLAE DSQEKFWNFV EASQNIGSSD HDGTDYSYYH AILEAAFQFL SPLQQNLFKF
     CLSLRSYSAT IQAFQQIAAD EPPPEGCNSF FSVHGKKTCE SDTLEALLLT ASERPKPLLF
     KGDHRYPSSN PESPVVIFYS EIGSEEFSNF HRQLISKSNA GKINYVFRHY IFNPRKEPVY
     LSGYGVELAI KSTEYKAKDD TQVKGTEVNT TVIGENDPID EVQGFLFGKL RDLHPDLEGQ
     LKELRKHLVE STNEMAPLKV WQLQDLSFQT AARILASPVE LALVVMKDLS QNFPTKARAI
     TKTAVSSELR TEVEENQKYF KGTLGLQPGD SALFINGLHM DLDTQDIFSL FDVLRNEARV
     MEGLHRLGIE GLSLHNVLKL NIQPSEADYA VDIRSPAISW VNNLEVDSRY NSWPSSLQEL
     LRPTFPGVIR QIRKNLHNMV FIVDPAHETT AELMNTAEMF LSNHIPLRIG FIFVVNDSED
     VDGMQDAGVA VLRAYNYVAQ EVDDYHAFQT LTHIYNKVRT GEKVKVEHVV SVLEKKYPYV
     EVNSILGIDS AYDRNRKEAR GYYEQTGVGP LPVVLFNGMP FEREQLDPDE LETITMHKIL
     ETTTFFQRAV YLGELPHDQD VVEYIMNQPN VVPRINSRIL TAERDYLDLT ASNNFFVDDY
     ARFTILDSQG KTAAVANSMN YLTKKGMSSK EIYDDSFIRP VTFWIVGDFD SPSGRQLLYD
     AIKHQKSSNN VRISMINNPA KEISYENTQI SRAIWAALQT QTSNAAKNFI TKMAKEGAAE
     ALAAGADIAE FSVGGMDFSL FKEVFESSKM DFILSHAVYC RDVLKLKKGQ RAVISNGRII
     GPLEDSELFN QDDFHLLENI ILKTSGQKIK SHIQQLRVEE DVASDLVMKV DALLSAQPKG
     DPRIEYQFFE DRHSAIKLRP KEGETYFDVV AVVDPVTREA QRLAPLLLVL AQLINMNLRV
     FMNCQSKLSD MPLKSFYRYV LEPEISFTSD NSFAKGPIAK FLDMPQSPLF TLNLNTPESW
     MVESVRTPYD LDNIYLEEVD SVVAAEYELE YLLLEGHCYD ITTGQPPRGL QFTLGTSANP
     VIVDTIVMAN LGYFQLKANP GAWILRLRKG RSEDIYRIYS HDGTDSPPDA DEVVIVLNNF
     KSKIIKVKVQ KKADMVNEDL LSDGTSENES GFWDSFKWGF TGQKTEEVKQ DKDDIINIFS
     VASGHLYERF LRIMMLSVLK NTKTPVKFWF LKNYLSPTFK EFIPYMANEY NFQYELVQYK
     WPRWLHQQTE KQRIIWGYKI LFLDVLFPLV VDKFLFVDAD QIVRTDLKEL RDFNLDGAPY
     GYTPFCDSRR EMDGYRFWKS GYWASHLAGR KYHISALYVV DLKKFRKIAA GDRLRGQYQG
     LSQDPNSLSN LDQDLPNNMI HQVPIKSLPQ EWLWCETWCD DASKKRAKTI DLCNNPMTKE
     PKLEAAVRIV PEWQDYDQEI KQLQIRFQKE KETGALYKEK TKEPSREGPQ KREEL
//
